scispace - formally typeset
S

Samuel I. Stupp

Researcher at Northwestern University

Publications -  587
Citations -  54611

Samuel I. Stupp is an academic researcher from Northwestern University. The author has contributed to research in topics: Peptide amphiphile & Supramolecular chemistry. The author has an hindex of 109, co-authored 560 publications receiving 49166 citations. Previous affiliations of Samuel I. Stupp include Urbana University & Max Planck Society.

Papers
More filters
Journal ArticleDOI

Permanent polarization in poly(acrylonitrile)

TL;DR: The dielectric behavior of poly(acrylonitrile) (PAN) has been investigated through the formation of electrically polarized films by the application of electric fields of the order 104 V cm−1 at temperatures ranging from 130 to 160°C.
Journal ArticleDOI

Self-assembled peptide nanostructures targeting death receptor 5 and encapsulating paclitaxel as a multifunctional cancer therapy.

TL;DR: A peptide amphiphile (PA) containing a dimeric, cyclic peptide that self-assembles into cylindrical supramolecular nanofibers and targets DR5 shows potent antitumor activity in vivo, demonstrating the multifunctional capabilities of peptide-based supramolescular nanostructures.
Journal ArticleDOI

Selective visible-light photocatalysis of acetylene to ethylene using a cobalt molecular catalyst and water as a proton source

TL;DR: In this paper , a photocatalytic system that reduces acetylene to ethylene with ≥99% selectivity under both noncompetitive (no ethylene cofeed) and competitive (ethylene co-feed) conditions, and near 100% conversion under the latter industrially relevant conditions, is presented.
Patent

Aligned nanofibers and related methods of use

TL;DR: In this paper, the authors presented aligned nanofiber bundle assemblies for tissue regeneration, controlled growth of cells, and related methods (e.g., diagnostic methods, research methods, drug screening).
Journal ArticleDOI

Self-assembling vascular endothelial growth factor nanoparticles improve function in spinocerebellar ataxia type 1.

TL;DR: A synthetic VEGF peptide amphiphile that self-assembles into nanoparticles has potent neurotrophic and angiogenic properties, is well-tolerated, and leads to functional improvement in SCA1 mice even when administered at advanced stages of the disease.